Global Prostate Cancer Diagnosis and Treatment Market Growth (Status and Outlook) 2023-2028

Report ID: 1507528 | Published Date: Jan 2025 | No. of Page: 120 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Prostate Cancer Diagnosis and Treatment Market Size 2017-2028
        2.1.2 Prostate Cancer Diagnosis and Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Prostate Cancer Diagnosis and Treatment Segment by Type
        2.2.1 Prostate Specific Antigen Test (PSA)
        2.2.2 Digital Rectal Exam (DRE)
    2.3 Prostate Cancer Diagnosis and Treatment Market Size by Type
        2.3.1 Prostate Cancer Diagnosis and Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Prostate Cancer Diagnosis and Treatment Market Size Market Share by Type (2017-2022)
    2.4 Prostate Cancer Diagnosis and Treatment Segment by Application
        2.4.1 Hospitals
        2.4.2 Diagnostic clinics
        2.4.3 Research centers
    2.5 Prostate Cancer Diagnosis and Treatment Market Size by Application
        2.5.1 Prostate Cancer Diagnosis and Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Prostate Cancer Diagnosis and Treatment Market Size Market Share by Application (2017-2022)
3 Prostate Cancer Diagnosis and Treatment Market Size by Player
    3.1 Prostate Cancer Diagnosis and Treatment Market Size Market Share by Players
        3.1.1 Global Prostate Cancer Diagnosis and Treatment Revenue by Players (2020-2022)
        3.1.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Players (2020-2022)
    3.2 Global Prostate Cancer Diagnosis and Treatment Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Prostate Cancer Diagnosis and Treatment by Regions
    4.1 Prostate Cancer Diagnosis and Treatment Market Size by Regions (2017-2022)
    4.2 Americas Prostate Cancer Diagnosis and Treatment Market Size Growth (2017-2022)
    4.3 APAC Prostate Cancer Diagnosis and Treatment Market Size Growth (2017-2022)
    4.4 Europe Prostate Cancer Diagnosis and Treatment Market Size Growth (2017-2022)
    4.5 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022)
    5.2 Americas Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022)
    5.3 Americas Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Prostate Cancer Diagnosis and Treatment Market Size by Region (2017-2022)
    6.2 APAC Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022)
    6.3 APAC Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Prostate Cancer Diagnosis and Treatment by Country (2017-2022)
    7.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022)
    7.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment by Region (2017-2022)
    8.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022)
    8.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Prostate Cancer Diagnosis and Treatment Market Forecast
    10.1 Global Prostate Cancer Diagnosis and Treatment Forecast by Regions (2023-2028)
        10.1.1 Global Prostate Cancer Diagnosis and Treatment Forecast by Regions (2023-2028)
        10.1.2 Americas Prostate Cancer Diagnosis and Treatment Forecast
        10.1.3 APAC Prostate Cancer Diagnosis and Treatment Forecast
        10.1.4 Europe Prostate Cancer Diagnosis and Treatment Forecast
        10.1.5 Middle East & Africa Prostate Cancer Diagnosis and Treatment Forecast
    10.2 Americas Prostate Cancer Diagnosis and Treatment Forecast by Country (2023-2028)
        10.2.1 United States Prostate Cancer Diagnosis and Treatment Market Forecast
        10.2.2 Canada Prostate Cancer Diagnosis and Treatment Market Forecast
        10.2.3 Mexico Prostate Cancer Diagnosis and Treatment Market Forecast
        10.2.4 Brazil Prostate Cancer Diagnosis and Treatment Market Forecast
    10.3 APAC Prostate Cancer Diagnosis and Treatment Forecast by Region (2023-2028)
        10.3.1 China Prostate Cancer Diagnosis and Treatment Market Forecast
        10.3.2 Japan Prostate Cancer Diagnosis and Treatment Market Forecast
        10.3.3 Korea Prostate Cancer Diagnosis and Treatment Market Forecast
        10.3.4 Southeast Asia Prostate Cancer Diagnosis and Treatment Market Forecast
        10.3.5 India Prostate Cancer Diagnosis and Treatment Market Forecast
        10.3.6 Australia Prostate Cancer Diagnosis and Treatment Market Forecast
    10.4 Europe Prostate Cancer Diagnosis and Treatment Forecast by Country (2023-2028)
        10.4.1 Germany Prostate Cancer Diagnosis and Treatment Market Forecast
        10.4.2 France Prostate Cancer Diagnosis and Treatment Market Forecast
        10.4.3 UK Prostate Cancer Diagnosis and Treatment Market Forecast
        10.4.4 Italy Prostate Cancer Diagnosis and Treatment Market Forecast
        10.4.5 Russia Prostate Cancer Diagnosis and Treatment Market Forecast
    10.5 Middle East & Africa Prostate Cancer Diagnosis and Treatment Forecast by Region (2023-2028)
        10.5.1 Egypt Prostate Cancer Diagnosis and Treatment Market Forecast
        10.5.2 South Africa Prostate Cancer Diagnosis and Treatment Market Forecast
        10.5.3 Israel Prostate Cancer Diagnosis and Treatment Market Forecast
        10.5.4 Turkey Prostate Cancer Diagnosis and Treatment Market Forecast
        10.5.5 GCC Countries Prostate Cancer Diagnosis and Treatment Market Forecast
    10.6 Global Prostate Cancer Diagnosis and Treatment Forecast by Type (2023-2028)
    10.7 Global Prostate Cancer Diagnosis and Treatment Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Information
        11.1.2 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product Offered
        11.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Abbott Laboratories Main Business Overview
        11.1.5 Abbott Laboratories Latest Developments
    11.2 AbbVie
        11.2.1 AbbVie Company Information
        11.2.2 AbbVie Prostate Cancer Diagnosis and Treatment Product Offered
        11.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 AbbVie Main Business Overview
        11.2.5 AbbVie Latest Developments
    11.3 Active Biotech
        11.3.1 Active Biotech Company Information
        11.3.2 Active Biotech Prostate Cancer Diagnosis and Treatment Product Offered
        11.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Active Biotech Main Business Overview
        11.3.5 Active Biotech Latest Developments
    11.4 Amgen
        11.4.1 Amgen Company Information
        11.4.2 Amgen Prostate Cancer Diagnosis and Treatment Product Offered
        11.4.3 Amgen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Amgen Main Business Overview
        11.4.5 Amgen Latest Developments
    11.5 Astellas Pharma
        11.5.1 Astellas Pharma Company Information
        11.5.2 Astellas Pharma Prostate Cancer Diagnosis and Treatment Product Offered
        11.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Astellas Pharma Main Business Overview
        11.5.5 Astellas Pharma Latest Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Information
        11.6.2 AstraZeneca Prostate Cancer Diagnosis and Treatment Product Offered
        11.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 AstraZeneca Main Business Overview
        11.6.5 AstraZeneca Latest Developments
    11.7 Bavarian Nordic
        11.7.1 Bavarian Nordic Company Information
        11.7.2 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product Offered
        11.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Bavarian Nordic Main Business Overview
        11.7.5 Bavarian Nordic Latest Developments
    11.8 Bayer
        11.8.1 Bayer Company Information
        11.8.2 Bayer Prostate Cancer Diagnosis and Treatment Product Offered
        11.8.3 Bayer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Bayer Main Business Overview
        11.8.5 Bayer Latest Developments
    11.9 Bristol-Myers Squibb
        11.9.1 Bristol-Myers Squibb Company Information
        11.9.2 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product Offered
        11.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Bristol-Myers Squibb Main Business Overview
        11.9.5 Bristol-Myers Squibb Latest Developments
    11.10 Dendreon
        11.10.1 Dendreon Company Information
        11.10.2 Dendreon Prostate Cancer Diagnosis and Treatment Product Offered
        11.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Dendreon Main Business Overview
        11.10.5 Dendreon Latest Developments
    11.11 Endo
        11.11.1 Endo Company Information
        11.11.2 Endo Prostate Cancer Diagnosis and Treatment Product Offered
        11.11.3 Endo Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Endo Main Business Overview
        11.11.5 Endo Latest Developments
    11.12 Ferring Pharmaceuticals
        11.12.1 Ferring Pharmaceuticals Company Information
        11.12.2 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product Offered
        11.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Ferring Pharmaceuticals Main Business Overview
        11.12.5 Ferring Pharmaceuticals Latest Developments
    11.13 GE Healthcare
        11.13.1 GE Healthcare Company Information
        11.13.2 GE Healthcare Prostate Cancer Diagnosis and Treatment Product Offered
        11.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 GE Healthcare Main Business Overview
        11.13.5 GE Healthcare Latest Developments
    11.14 GSK
        11.14.1 GSK Company Information
        11.14.2 GSK Prostate Cancer Diagnosis and Treatment Product Offered
        11.14.3 GSK Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 GSK Main Business Overview
        11.14.5 GSK Latest Developments
    11.15 Ipsen
        11.15.1 Ipsen Company Information
        11.15.2 Ipsen Prostate Cancer Diagnosis and Treatment Product Offered
        11.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Ipsen Main Business Overview
        11.15.5 Ipsen Latest Developments
    11.16 Johnson & Johnson
        11.16.1 Johnson & Johnson Company Information
        11.16.2 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Product Offered
        11.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Johnson & Johnson Main Business Overview
        11.16.5 Johnson & Johnson Latest Developments
    11.17 Pfizer
        11.17.1 Pfizer Company Information
        11.17.2 Pfizer Prostate Cancer Diagnosis and Treatment Product Offered
        11.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 Pfizer Main Business Overview
        11.17.5 Pfizer Latest Developments
    11.18 Sanofi
        11.18.1 Sanofi Company Information
        11.18.2 Sanofi Prostate Cancer Diagnosis and Treatment Product Offered
        11.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 Sanofi Main Business Overview
        11.18.5 Sanofi Latest Developments
    11.19 Siemens Healthineers
        11.19.1 Siemens Healthineers Company Information
        11.19.2 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Product Offered
        11.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.19.4 Siemens Healthineers Main Business Overview
        11.19.5 Siemens Healthineers Latest Developments
    11.20 Takeda
        11.20.1 Takeda Company Information
        11.20.2 Takeda Prostate Cancer Diagnosis and Treatment Product Offered
        11.20.3 Takeda Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.20.4 Takeda Main Business Overview
        11.20.5 Takeda Latest Developments
    11.21 Teva Pharmaceutical
        11.21.1 Teva Pharmaceutical Company Information
        11.21.2 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Product Offered
        11.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.21.4 Teva Pharmaceutical Main Business Overview
        11.21.5 Teva Pharmaceutical Latest Developments
    11.22 Tolmar Pharmaceuticals
        11.22.1 Tolmar Pharmaceuticals Company Information
        11.22.2 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product Offered
        11.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2020-2022)
        11.22.4 Tolmar Pharmaceuticals Main Business Overview
        11.22.5 Tolmar Pharmaceuticals Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Prostate Cancer Diagnosis and Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Prostate Specific Antigen Test (PSA)
    Table 3. Major Players of Digital Rectal Exam (DRE)
    Table 4. Prostate Cancer Diagnosis and Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 5. Global Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022) & ($ Millions)
    Table 6. Global Prostate Cancer Diagnosis and Treatment Market Size Market Share by Type (2017-2022)
    Table 7. Prostate Cancer Diagnosis and Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022) & ($ Millions)
    Table 9. Global Prostate Cancer Diagnosis and Treatment Market Size Market Share by Application (2017-2022)
    Table 10. Global Prostate Cancer Diagnosis and Treatment Revenue by Players (2020-2022) & ($ Millions)
    Table 11. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Player (2020-2022)
    Table 12. Prostate Cancer Diagnosis and Treatment Key Players Head office and Products Offered
    Table 13. Prostate Cancer Diagnosis and Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 14. New Products and Potential Entrants
    Table 15. Mergers & Acquisitions, Expansion
    Table 16. Global Prostate Cancer Diagnosis and Treatment Market Size by Regions 2017-2022 & ($ Millions)
    Table 17. Global Prostate Cancer Diagnosis and Treatment Market Size Market Share by Regions (2017-2022)
    Table 18. Americas Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022) & ($ Millions)
    Table 19. Americas Prostate Cancer Diagnosis and Treatment Market Size Market Share by Country (2017-2022)
    Table 20. Americas Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022) & ($ Millions)
    Table 21. Americas Prostate Cancer Diagnosis and Treatment Market Size Market Share by Type (2017-2022)
    Table 22. Americas Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022) & ($ Millions)
    Table 23. Americas Prostate Cancer Diagnosis and Treatment Market Size Market Share by Application (2017-2022)
    Table 24. APAC Prostate Cancer Diagnosis and Treatment Market Size by Region (2017-2022) & ($ Millions)
    Table 25. APAC Prostate Cancer Diagnosis and Treatment Market Size Market Share by Region (2017-2022)
    Table 26. APAC Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022) & ($ Millions)
    Table 27. APAC Prostate Cancer Diagnosis and Treatment Market Size Market Share by Type (2017-2022)
    Table 28. APAC Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022) & ($ Millions)
    Table 29. APAC Prostate Cancer Diagnosis and Treatment Market Size Market Share by Application (2017-2022)
    Table 30. Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2017-2022) & ($ Millions)
    Table 31. Europe Prostate Cancer Diagnosis and Treatment Market Size Market Share by Country (2017-2022)
    Table 32. Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022) & ($ Millions)
    Table 33. Europe Prostate Cancer Diagnosis and Treatment Market Size Market Share by Type (2017-2022)
    Table 34. Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022) & ($ Millions)
    Table 35. Europe Prostate Cancer Diagnosis and Treatment Market Size Market Share by Application (2017-2022)
    Table 36. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Region (2017-2022) & ($ Millions)
    Table 37. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size Market Share by Region (2017-2022)
    Table 38. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2017-2022) & ($ Millions)
    Table 39. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size Market Share by Type (2017-2022)
    Table 40. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size Market Share by Application (2017-2022)
    Table 42. Key Market Drivers & Growth Opportunities of Prostate Cancer Diagnosis and Treatment
    Table 43. Key Market Challenges & Risks of Prostate Cancer Diagnosis and Treatment
    Table 44. Key Industry Trends of Prostate Cancer Diagnosis and Treatment
    Table 45. Global Prostate Cancer Diagnosis and Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 46. Global Prostate Cancer Diagnosis and Treatment Market Size Market Share Forecast by Regions (2023-2028)
    Table 47. Global Prostate Cancer Diagnosis and Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 48. Global Prostate Cancer Diagnosis and Treatment Market Size Market Share Forecast by Type (2023-2028)
    Table 49. Global Prostate Cancer Diagnosis and Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 50. Global Prostate Cancer Diagnosis and Treatment Market Size Market Share Forecast by Application (2023-2028)
    Table 51. Abbott Laboratories Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 52. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product Offered
    Table 53. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 54. Abbott Laboratories Main Business
    Table 55. Abbott Laboratories Latest Developments
    Table 56. AbbVie Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 57. AbbVie Prostate Cancer Diagnosis and Treatment Product Offered
    Table 58. AbbVie Main Business
    Table 59. AbbVie Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 60. AbbVie Latest Developments
    Table 61. Active Biotech Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 62. Active Biotech Prostate Cancer Diagnosis and Treatment Product Offered
    Table 63. Active Biotech Main Business
    Table 64. Active Biotech Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 65. Active Biotech Latest Developments
    Table 66. Amgen Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 67. Amgen Prostate Cancer Diagnosis and Treatment Product Offered
    Table 68. Amgen Main Business
    Table 69. Amgen Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 70. Amgen Latest Developments
    Table 71. Astellas Pharma Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 72. Astellas Pharma Prostate Cancer Diagnosis and Treatment Product Offered
    Table 73. Astellas Pharma Main Business
    Table 74. Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 75. Astellas Pharma Latest Developments
    Table 76. AstraZeneca Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 77. AstraZeneca Prostate Cancer Diagnosis and Treatment Product Offered
    Table 78. AstraZeneca Main Business
    Table 79. AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 80. AstraZeneca Latest Developments
    Table 81. Bavarian Nordic Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 82. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product Offered
    Table 83. Bavarian Nordic Main Business
    Table 84. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 85. Bavarian Nordic Latest Developments
    Table 86. Bayer Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 87. Bayer Prostate Cancer Diagnosis and Treatment Product Offered
    Table 88. Bayer Main Business
    Table 89. Bayer Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 90. Bayer Latest Developments
    Table 91. Bristol-Myers Squibb Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 92. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product Offered
    Table 93. Bristol-Myers Squibb Main Business
    Table 94. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 95. Bristol-Myers Squibb Latest Developments
    Table 96. Dendreon Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 97. Dendreon Prostate Cancer Diagnosis and Treatment Product Offered
    Table 98. Dendreon Main Business
    Table 99. Dendreon Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 100. Dendreon Latest Developments
    Table 101. Endo Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 102. Endo Prostate Cancer Diagnosis and Treatment Product Offered
    Table 103. Endo Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 104. Endo Main Business
    Table 105. Endo Latest Developments
    Table 106. Ferring Pharmaceuticals Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 107. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product Offered
    Table 108. Ferring Pharmaceuticals Main Business
    Table 109. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 110. Ferring Pharmaceuticals Latest Developments
    Table 111. GE Healthcare Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 112. GE Healthcare Prostate Cancer Diagnosis and Treatment Product Offered
    Table 113. GE Healthcare Main Business
    Table 114. GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 115. GE Healthcare Latest Developments
    Table 116. GSK Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 117. GSK Prostate Cancer Diagnosis and Treatment Product Offered
    Table 118. GSK Main Business
    Table 119. GSK Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 120. GSK Latest Developments
    Table 121. Ipsen Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 122. Ipsen Prostate Cancer Diagnosis and Treatment Product Offered
    Table 123. Ipsen Main Business
    Table 124. Ipsen Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 125. Ipsen Latest Developments
    Table 126. Johnson & Johnson Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 127. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Product Offered
    Table 128. Johnson & Johnson Main Business
    Table 129. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 130. Johnson & Johnson Latest Developments
    Table 131. Pfizer Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 132. Pfizer Prostate Cancer Diagnosis and Treatment Product Offered
    Table 133. Pfizer Main Business
    Table 134. Pfizer Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 135. Pfizer Latest Developments
    Table 136. Sanofi Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 137. Sanofi Prostate Cancer Diagnosis and Treatment Product Offered
    Table 138. Sanofi Main Business
    Table 139. Sanofi Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 140. Sanofi Latest Developments
    Table 141. Siemens Healthineers Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 142. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Product Offered
    Table 143. Siemens Healthineers Main Business
    Table 144. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 145. Siemens Healthineers Latest Developments
    Table 146. Takeda Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 147. Takeda Prostate Cancer Diagnosis and Treatment Product Offered
    Table 148. Takeda Main Business
    Table 149. Takeda Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 150. Takeda Latest Developments
    Table 151. Teva Pharmaceutical Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 152. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Product Offered
    Table 153. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 154. Teva Pharmaceutical Main Business
    Table 155. Teva Pharmaceutical Latest Developments
    Table 156. Tolmar Pharmaceuticals Details, Company Type, Prostate Cancer Diagnosis and Treatment Area Served and Its Competitors
    Table 157. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product Offered
    Table 158. Tolmar Pharmaceuticals Main Business
    Table 159. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 160. Tolmar Pharmaceuticals Latest Developments
List of Figures
    Figure 1. Prostate Cancer Diagnosis and Treatment Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Prostate Cancer Diagnosis and Treatment Market Size Market Share by Type in 2021
    Figure 7. Prostate Cancer Diagnosis and Treatment in Hospitals
    Figure 8. Global Prostate Cancer Diagnosis and Treatment Market: Hospitals (2017-2022) & ($ Millions)
    Figure 9. Prostate Cancer Diagnosis and Treatment in Diagnostic clinics
    Figure 10. Global Prostate Cancer Diagnosis and Treatment Market: Diagnostic clinics (2017-2022) & ($ Millions)
    Figure 11. Prostate Cancer Diagnosis and Treatment in Research centers
    Figure 12. Global Prostate Cancer Diagnosis and Treatment Market: Research centers (2017-2022) & ($ Millions)
    Figure 13. Global Prostate Cancer Diagnosis and Treatment Market Size Market Share by Application in 2021
    Figure 14. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Player in 2021
    Figure 15. Global Prostate Cancer Diagnosis and Treatment Market Size Market Share by Regions (2017-2022)
    Figure 16. Americas Prostate Cancer Diagnosis and Treatment Market Size 2017-2022 ($ Millions)
    Figure 17. APAC Prostate Cancer Diagnosis and Treatment Market Size 2017-2022 ($ Millions)
    Figure 18. Europe Prostate Cancer Diagnosis and Treatment Market Size 2017-2022 ($ Millions)
    Figure 19. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size 2017-2022 ($ Millions)
    Figure 20. Americas Prostate Cancer Diagnosis and Treatment Value Market Share by Country in 2021
    Figure 21. Americas Prostate Cancer Diagnosis and Treatment Consumption Market Share by Type in 2021
    Figure 22. Americas Prostate Cancer Diagnosis and Treatment Market Size Market Share by Application in 2021
    Figure 23. United States Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Canada Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 25. Mexico Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Brazil Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 27. APAC Prostate Cancer Diagnosis and Treatment Market Size Market Share by Region in 2021
    Figure 28. APAC Prostate Cancer Diagnosis and Treatment Market Size Market Share by Application in 2021
    Figure 29. China Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Japan Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 31. Korea Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 33. India Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Australia Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Europe Prostate Cancer Diagnosis and Treatment Market Size Market Share by Country in 2021
    Figure 36. Europe Prostate Cancer Diagnosis and Treatment Market Size Market Share by Type in 2021
    Figure 37. Europe Prostate Cancer Diagnosis and Treatment Market Size Market Share by Application in 2021
    Figure 38. Germany Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 39. France Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 40. UK Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Italy Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 42. Russia Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size Market Share by Region in 2021
    Figure 44. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size Market Share by Type in 2021
    Figure 45. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size Market Share by Application in 2021
    Figure 46. Egypt Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 47. South Africa Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 48. Israel Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Turkey Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 50. GCC Country Prostate Cancer Diagnosis and Treatment Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Americas Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 52. APAC Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 53. Europe Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 54. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 55. United States Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 56. Canada Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 57. Mexico Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 58. Brazil Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 59. China Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 60. Japan Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 61. Korea Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 62. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 63. India Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 64. Australia Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 65. Germany Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 66. France Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 67. UK Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 68. Italy Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 69. Russia Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 70. Spain Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 71. Egypt Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 72. South Africa Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 73. Israel Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 74. Turkey Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
    Figure 75. GCC Countries Prostate Cancer Diagnosis and Treatment Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Prostate Cancer Diagnosis and Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Prostate Cancer Diagnosis and Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Prostate Cancer Diagnosis and Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports